Brief: Mereo Biopharma Sends Letter To Rubric Capital Management
31/08/2022 12:24
Aug 31 (Reuters) - Mereo Biopharma Group PLC MAH0y.F :
* MEREO BIOPHARMA SENDS LETTER TO RUBRIC CAPITAL MANAGEMENT
* MEREO BIOPHARMA GROUP PLC - LETTER REITERATES MEREO'S
UPDATED
STRATEGIC PLAN TO MAXIMIZE VALUE FOR ALL SHAREHOLDERS AND
CORRECTS RUBRIC'S ASSUMPTIONS
* MEREO BIOPHARMA GROUP PLC - ANNOUNCES FURTHER EXTENSION OF
CASH
RUNWAY INTO Q2 2025
Source text for Eikon: ID:nGNX5bYByH
Further company coverage: MAH0y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mereo BioPharma
See all newsBrief: Sentynl Therapeutics And Mereo Biopharma Announce Option And License Agreement For Alvelestat In Alpha-1 Antitrypsin Deficiency-Associated Lung Disease
UK's Mereo BioPharma Q2 loss narrows on lower R&D spending
Brief: Mereo BioPharma Q2 Operating Income USD -7.03 Million
Brief: Mereo BioPharma Q1 Net Income USD -6.719 Million
Brief: Mereo BioPharma FY Revenue USD 500 Thousand Vs. IBES Estimate USD 520 Thousand